ObsEva SA to Participate in Upcoming Investor Conferences
01 avr. 2019 01h00 HE
|
ObsEva SA
Geneva, Switzerland and Boston, MA – April 1, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...